This is just a snapshot of Day Two.
For complete details please download our conference brochure.
| 8:00 | Morning Coffee |
| 8:45 |
Co-Chairperson's Opening Remarks Vickie O'Neill, Vice President of Research and Technology Development |
| 9:00 | Annual View from Wall Street: Changes, Opportunities, and Outlook for the Generics Industry
Richard B. Silver, Senior Vice President, Specialty Pharmaceuticals Research LEHMAN BROTHERS |
| 10:00 |
CEO Roundtable: The Changing Competitive Landscape of the Generic Drugs Industry
Moderator:
Panelists:
Arthur P. Bedrosian, J.D. Art Koch Venkatachalam Krishnan
|
| 10:45 | Morning Refreshment and Networking Break |
| 11:00 |
Featured Panel Session: Legislative Impact on Generic Drugs
Moderator:
Panelists:
Ted Lingerfeldt, Director of Pharmacy Procurement
Edith A. Rosato, RPh, Senior Vice President, Strategic Alliances and Development Executive Director
Steve Goodman, RPh, Vice President of Marketing--Generics
William C. Kennally, President |
| 12:15 | Luncheon for Delegates and Speakers |
|
Track A: Intellectual Property & Legal Issues
|
Track B: Business Development
|
|
1:30 Proposed Patent Reform and its Likely Effect on Generic Drug Litigation Steven J. Lee, PhD, Vice President – Partner
|
1:30 505(b)(2): Risks and Rewards of Generic Innovation Vickie O'Neill, Vice President of Research and Technology Development
|
|
2:15 New Roadblocks on the Path to Generic Entry: Authorized Generics and Brand Extension Strategies David Balto Partner |
2:15 Business Perspectives: Challenges and Opportunities in India Venkatachalam Krishnan, Vice President
|
| 3:00 Conference Concludes | |
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved